Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 12.024\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1cc2occ(CC(=O)N(C)CC(=O)Nc3c(C)cccc3C)c2cc1C
b: CC(C)N(Cc1nnc(-c2ccccc2Br)o1)C(=O)c1cc(Cl)nc2ccccc12
Answer: b. CC(C)N(Cc1nnc(-c2ccccc2Br)o1)C(=O)c1cc(Cl)nc2ccccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)N(Cc1nnc(-c2ccccc2Br)o1)C(=O)c1cc(Cl)nc2ccccc12
CC(C)N(Cc1nnc(-c2ccccc2Br)o1)C(=O)c1cc(Cl)nc2ccccc12
N-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]methyl]-2-chloro-N-propan-2-ylquinoline-4-carboxamide